Lortet-Tieulent J,Ferlay J,Bray F,Jemal A .2018 .International patterns and trends in endometrial cancer incidence,. J Natl Cancer Inst, 110(4) : 354-61.
Kobayashi Y,Kitazono I,Akahane T,Yanazume S,Kamio M,Togami S .2021 .Molecular evaluation of endometrial dedifferentiated carcinoma, endometrioid carcinoma, carcinosarcoma, and serous carcinoma using a custom-made small cancer panel. Pathol Oncol Res, 27 : 1610013.
Huvila J,Pors J,Thompson EF,Gilks CB .2021 .Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis. J Pathol, 253(4) : 355-65.
Santoro A,Angelico G,Travaglino A,Inzani F,Arciuolo D,Valente M .2021 .New pathological and clinical insights in endometrial cancer in view of the updated ESGO/ESTRO/ESP guidelines. Cancers, 13(11) : 2623.
Kasius JC,Pijnenborg JM,Lindemann K,Forsse D,van Zwol J,Kristensen GB .2021 .Risk stratification of endometrial cancer patients: FIGO stage, biomarkers and molecular classification. Cancers, 13(22) : 5848.
Hamilton SN,Tinker AV,Kwon J,Lim P,Kong I,Sihra S .2022 .Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma. J Gynecol Oncol, 33(3) : e25.
Li Z,Zhao C .2016 .Clinicopathologic and immunohistochemical characterization of dedifferentiated endometrioid adenocarcinoma. Appl Immunohistochem Mol Morphol, 24(8) : 562-8.
Bansal N,Herzog TJ,Seshan VE,Schiff PB,Burke WM,Cohen CJ .2008 .Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumour behavior. Obstet Gynecol, 112(1) : 64-70.
Lakhwani P,Agarwal P,Goel A,Nayar N,Pande P,Kumar K.,High-Grade Endometrial K. .2019 .Outcomes at a Tertiary Cancer Centre. Indian J Surg Oncol, 10(4) : 662-7.
Murali R,Davidson B,Fadare O,Carlson JA,Crum CP,Gilks CB .2019 .High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations. Int J Gynecol Pathol, 38(Suppl 1) : S40-63.
Taskin OÇ,Onder S,Topuz S,Sozen H,Sen F,Ilhan R .2017 .A selected immunohistochemical panel aids in differential diagnosis and prognostic stratification of subtypes of highgrade endometrial carcinoma: a clinicopathologic and immunohistochemical study at a single institution. Appl Immunohistochem Mol Morphol, 25(10) : 696-702.
Paulino E .2023 .Clinical Characteristics and Outcomes of a High-grade Endometrial Cancer Cohort Treated. Brazil. Rev Bras Ginecol Obstet, 45(7) : e401-8.
Ercelep O,Gumus M. .2019 .Comparison of clinicopathologic and survival characteristics of high-grade endometrial cancers; single center experience. Curr Probl Cancer, 43(2) : 160-6.
Silva EG,Deavers MT,Bodurka DC,Malpica A .2006 .Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?. Int J Gynecol Pathol, 25(1) : 52-8.
Zhang K,Liu Y,Liu X,Du J,Wang Y,Yang J .2021 .Clinicopathological significance of multiple molecular features in undifferentiated and dedifferentiated endometrial carcinomas. Pathology, 53(2) : 179-86.
Scharl S,Sprötge T,Gerken M,Scharl A,Ortmann O,Kölbl O .2023 .Guideline concordant therapy improves survival in high-grade endometrial cancer patients. J Cancer Res Clin Oncol, 149(8) : 4761-9.
Sohaib SA,Houghton SL,Meroni R,Rockall AG,Blake P,Reznek RH .2007 .Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. Clin Radiol, 62(1) : 28-34.
Tafe LJ,Garg K,Chew I,Tornos C,Soslow RA .2010 .Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms. Mod Pathol, 23(6) : 781-9.
Altrabulsi B,Malpica A,Deavers MT,Bodurka DC,Broaddus R,Silva EG .2005 .Undifferentiated carcinoma of the endometrium. Am J Surg Pathol, 29(10) : 1316-21.
Al-Hussaini M,Lataifeh I,Jaradat I,Abdeen G,Otay L,Badran O .2018 .Undifferentiated endometrial carcinoma, an immunohistochemical study including PD-L1 testing of a series of cases from a single cancer center. Int J Gynecol Pathol, 37(6) : 564-74.
Üreyen I,Ilgin H,Turan T,Taşçi T,Karalök A,Boran N,Elson P,Rybicki L,Amarnath S,Yang B,Michener CM .2019 .Undifferentiated endometrial carcinoma: a National Cancer Database analysis of prognostic factors and treatment outcomes. Int J Gynecol Cancer, 29(7) : 1126-33.
Gracia M,Yildirim Y,Macuks R,Mancari R,AchimasCadariu P,Polterauer S .2023 .Influence of clinical and surgical factors on uterine carcinosarcoma survival. Cancers, 15(5) : 1463.
Chiang CY,Huang HJ,Chang WY,Yang LY,Wu RC,Wang CC .2021 .Adjuvant therapy and prognosis in uterine carcinosarcoma. J Formos Med Assoc, 120(11) : 1977-87.
Bosquet JG,Terstriep SA,Cliby WA,Brown-Jones M,Kaur JS,Podratz KC .2010 .The impact of multi-modal therapy on survival for uterine carcinosarcomas. Gynecol Oncol, 116(3) : 419-23.
.2024 .. 2024 Revised: September, 25 : .